Hematological disorders: a commonly unrecognized cause of acute stroke

A Arboix, C Jiménez, J Massons, O Parra… - Expert review of …, 2016 - Taylor & Francis
Introduction: Hematological disorders account for about 1.3% of all causes of acute stroke.
This systematized review presents updated information on the implications of this category …

Adverse effects of heparin

S Alban - Heparin-a century of progress, 2012 - Springer
All the adverse effects of heparins are related to their wide variety of biological activities, with
bleeding being the most important safety issue, resulting directly from the potency of heparin …

Guidelines on the diagnosis and management of heparin-induced thrombocytopenia

H Watson, S Davidson… - British journal of …, 2012 - search.ebscohost.com
The article presents information on the diagnosis of the heparin-induced thrombocytopenia
(HIT). It informs about the diagnosis techniques used for HIT which includes enzyme-linked …

Taking immunogenicity assessment of therapeutic proteins to the next level

IC Büttel, P Chamberlain, Y Chowers, F Ehmann… - Biologicals, 2011 - Elsevier
Therapeutic proteins provide innovative and effective therapies for numerous diseases.
However, some of these products are associated with unwanted immunogenicity that may …

Coagulation management in patients undergoing mechanical circulatory support

K Görlinger, L Bergmann, D Dirkmann - Best practice & research Clinical …, 2012 - Elsevier
The incidence of bleeding and thrombo-embolic complications in patients undergoing
mechanical circulatory support therapy remains high and is associated with bad outcomes …

Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation

J Yeung, BE Tourdot… - Blood, The Journal …, 2014 - ashpublications.org
Platelets are essential in maintaining hemostasis following inflammation or injury to the
vasculature. Dysregulated platelet activity often results in thrombotic complications leading …

The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital

SY Lim, EJ Jeon, HJ Kim, K Jeon… - Journal of Korean …, 2012 - synapse.koreamed.org
This study was designed to investigate the incidence, causes, and outcomes of new-onset
thrombocytopenia (NOT) in Korean intensive care units (ICUs). A prospective cohort study …

Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart …

A Kaeberich, I Reindl, U Raaz, L Maegdefessel… - Journal of thrombosis …, 2011 - Springer
Thromboembolism and bleeding after mechanical heart valve replacement are still unsolved
problems, particularly for patients requiring anticoagulative bridging therapy. The aim of this …

Update on the safety and bioequivalence of biosimilars–focus on enoxaparin

W Jeske, JM Walenga, D Hoppensteadt… - Drug, healthcare and …, 2013 - Taylor & Francis
Generic forms of chemically-derived drugs must exhibit chemical identity and be
bioequivalent in healthy human subjects. The use of generic drugs results in a considerable …

An optimized and standardized rapid flow cytometry functional method for heparin-induced thrombocytopenia

A Runser, C Schaning, F Allemand, J Amiral - Biomedicines, 2021 - mdpi.com
Heparin-induced thrombocytopenia (HIT) is a thrombocytopenia caused by heparin and
mediated by an atypical immune mechanism leading to a paradoxical high thrombotic risk …